{"id":"W2890646471","doi":"10.1200/jco.2018.36.15_suppl.4084","title":"Selumetinib (Sel) and cisplatin/gemcitabine (CisGem) for advanced biliary tract cancer (BTC): A randomized trial.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary; Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Gemcitabine; Clinical endpoint; Toxicity; Internal medicine; Gastroenterology; Surgery; Urology; Randomized controlled trial; Cancer; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002013596,0.001510211,0.002049322,0.000435616,0.000290598,0.0008997901,0.0007065028,0.001346915,0.007830545],"category_scores_gemma":[0.001427251,0.0006448919,0.001505787,0.0004852259,0.0008536925,0.0008542524,0.0005382641,0.00225564,0.0009750666],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000834704,"about_ca_system_score_gemma":0.001248262,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009318623,"about_ca_topic_score_gemma":0.002518767,"domain_scores_codex":[0.9993705,0.0004093125,0.00003369205,0.00007915273,0.00003155268,0.00007575392],"domain_scores_gemma":[0.9993487,0.00015131,0.0001648968,0.00004459068,0.00003387871,0.0002566301],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9858124,0.002812659,0.0004439977,0.0003814479,0.0005628818,0.00002494607,0.00002132762,0.0002621615,0.001120962,0.00006776641,0.0005344028,0.007954927],"study_design_scores_gemma":[0.9570997,0.04041193,0.0009657245,0.00002419869,0.000383427,0.00002530256,0.00001320683,0.0003080729,0.0001635184,0.00009368482,0.0005045311,0.000006612494],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9827507,0.005397296,0.0004825428,0.001165108,0.0004634476,0.005108086,0.001515997,0.0001162395,0.003000593],"genre_scores_gemma":[0.9823927,0.003105741,0.001301887,0.001208796,0.0004520954,0.005844504,0.001564097,0.00002019771,0.004110042],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007830545,"threshold_uncertainty_score":0.0261957,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1342594032572225,"score_gpt":0.499059683410932,"score_spread":0.3648002801537095,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}